[CLDX] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
07-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 31.67%
YoY- 28.21%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 2,728 887 546 715 1,425 1,764 941 103.18%
PBT -12,625 -10,447 -11,413 -11,779 -17,239 -9,402 -7,243 44.78%
Tax -16 -4,448 -5,090 -2,990 5,234 -8,746 -14,912 -98.94%
NP -12,625 -10,447 -11,413 -11,779 -17,239 -9,402 -7,243 44.78%
Tax Rate - - - - - - - -
Total Cost 15,353 11,334 11,959 12,494 18,664 11,166 8,184 52.04%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -462.79 -1,177.79 -2,090.29 -1,647.41 -1,209.75 -532.99 -769.71 -28.74%
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -0.73 -0.64 -0.75 -0.84 -1.40 -0.81 -0.66 6.94%
EPS Diluted -0.73 -0.64 -0.75 -0.84 -1.40 -0.81 -0.66 6.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.